Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewImiloxan hydrochloride
Description: Highly selective α2B antagonist
Alternative Names: RS 21361
Chemical Name: 2-(1-Ethyl-2-indazoyl)methyl-1,4-benzodioxan hydrochloride
Purity: ≥98% (HPLC)
Biological Activity for Imiloxan hydrochloride
Imiloxan hydrochloride is a moderately potent, but highly selective α2-adrenoceptor antagonist, the only reported selective antagonist at the α2B-adrenoceptor not having potent α1-adrenoceptor antagonist activity.
Licensing Information
Sold with the permission of Roche Bioscience
Technical Data for Imiloxan hydrochloride
| M. Wt | 280.75 |
| Formula | C14H16N2O2.HCl |
| Storage | Desiccate at RT |
| Purity | ≥98% (HPLC) |
| CAS Number | 81167-22-8 |
| PubChem ID | 172975 |
| InChI Key | ANDJPJNFVJXEKX-UHFFFAOYSA-N |
| Smiles | Cl.CCN1C=CN=C1CC1COC2=CC=CC=C2O1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for Imiloxan hydrochloride
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| water | 28.07 | 100 |
Preparing Stock Solutions for Imiloxan hydrochloride
The following data is based on the product molecular weight 280.75. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 3.56 mL | 17.81 mL | 35.62 mL |
| 5 mM | 0.71 mL | 3.56 mL | 7.12 mL |
| 10 mM | 0.36 mL | 1.78 mL | 3.56 mL |
| 50 mM | 0.07 mL | 0.36 mL | 0.71 mL |
Molarity Calculator
Molarity Calculator
Calculate the mass, volume, or concentration required for a solution.
Reconstitution Calculator
Reconstitution Calculator
Dilution Calculator
Dilution Calculator
Calculate the dilution required to prepare a stock solution.
Product Datasheets for Imiloxan hydrochloride
References for Imiloxan hydrochloride
References are publications that support the biological activity of the product.
Michel et al (1990) Assessment of imiloxan as a selective α2B-adrenoceptor antagonist. Br.J.Pharmacol. 99 560 PMID: 1970500
Michel and Whiting (1981) 2-(2-Imidazolylmethyl)-1,4-benzodioxans, a series of selective alpha2-adrenoceptor antagonists. Br.J.Pharmacol. 74 255P
If you know of a relevant reference for Imiloxan hydrochloride, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Imiloxan hydrochloride, Imiloxan hydrochloride supplier, selective, α2B-adrenoceptor, alpha2B-adrenoceptor, antagonists, α2b-adrenergic, alpha2b-adrenergic, a2-adrenoceptor, a2-adrenergic, Receptors, RS21361, RS, 21361, Adrenergic, Alpha-2, 0986, Tocris Bioscience
Citations for Imiloxan hydrochloride
Citations are publications that use Tocris products.
Currently there are no citations for Imiloxan hydrochloride. Do you know of a great paper that uses Imiloxan hydrochloride from Tocris? Please let us know.
Reviews for Imiloxan hydrochloride
There are currently no reviews for this product. Be the first to review Imiloxan hydrochloride and earn rewards!
Have you used Imiloxan hydrochloride?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Depression Poster
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.
Parkinson's Disease Poster
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.